Article Details
Retrieved on: 2022-01-10 13:31:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CHICAGO, Jan. 10, 2022 /PRNewswire/ -- Cour Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here